Sustained-release pharmaceutical composition for treatment and prevention of eye disease Grant US-10808006-B2 United States of America 20 Oct 2020
Sustained-release pharmaceutical composition for treatment and prevention of eye disease Grant US-10208082-B2 United States of America 19 Feb 2019